Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3647948
Max Phase: Preclinical
Molecular Formula: C23H28N2O3S
Molecular Weight: 412.56
Molecule Type: Small molecule
Associated Items:
ID: ALA3647948
Max Phase: Preclinical
Molecular Formula: C23H28N2O3S
Molecular Weight: 412.56
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CSc1ccc(/C=C(/C(=O)NCCCCCC(=O)NO)c2ccc(C)cc2)cc1
Standard InChI: InChI=1S/C23H28N2O3S/c1-17-7-11-19(12-8-17)21(16-18-9-13-20(29-2)14-10-18)23(27)24-15-5-3-4-6-22(26)25-28/h7-14,16,28H,3-6,15H2,1-2H3,(H,24,27)(H,25,26)/b21-16+
Standard InChI Key: SDHGLBIWGCIVEB-LTGZKZEYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 412.56 | Molecular Weight (Monoisotopic): 412.1821 | AlogP: 4.44 | #Rotatable Bonds: 10 |
Polar Surface Area: 78.43 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 8.91 | CX Basic pKa: | CX LogP: 4.45 | CX LogD: 4.43 |
Aromatic Rings: 2 | Heavy Atoms: 29 | QED Weighted: 0.13 | Np Likeness Score: -0.65 |
1. (2013) Histone deacetylase inhibitors, |
Source(1):